Pharmaceuticals giant Merck & Company (MRK) has cut its full-year profit forecasts fearing a $200 million hit from President ...

Over the past five years, the stock has recorded a negative one-day return in 65% of cases, with a median decline of -2.4% ...

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target ...